跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 901 条关于
“naltrexone/bupropion”
全部
901
临床试验
782
药物
57
机构
0
资讯
62
去年
Tirzepatide and Semaglutide Show Superior Weight Loss Efficacy in Meta-Analysis
3年前
Approved Anti-Obesity Medications in 2022: A Comprehensive Overview
上个月
Weight-Loss Medications Not Linked to Higher Respiratory Adverse Event Risk, Meta-Analysis Finds
去年
Weight Loss Drugs Wegovy and Zepbound Not Cost-Effective at Current Prices, Study Finds
去年
FDA Approves Second Manufacturing Site for CONTRAVE, Bolstering Supply Chain for Leading Oral Weight Loss Medication
去年
Significant Weight Gain Underreported in ALK+ Lung Cancer Patients on Alecensa Treatment
去年
EMA's CHMP Recommends Multiple New Medicines and расширения Indications in November and December 2024 Meetings
去年
Rising Costs and Coverage Challenges Shape Anti-Obesity Medication Landscape in US
去年
High-Fiber Diet Shows Promise in Obesity Management, Opening New Paths for Pharmaceutical Development
去年
EMA Confirms Mysimba's Cardiovascular Safety for One-Year Use in Weight Management
第 1 页,共 7 页
上一页
下一页